WCG is the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research. Comprised of two segments, Ethical Review and Clinical Trials Solutions (CTS), WCG enables biopharmaceutical companies, CROs, and institutions to advance the delivery of new treatments and therapies to patients, while maintaining the highest standards of human participant protection.


WCG IRB is rooted in an ongoing commitment to exceptional service, uncompromising integrity, unmatched industry expertise, and tireless innovation. We are proud to empower our clients in their mission to advancing health – then, now, and always.


Since 2000, WCG has provided personalized Institutional Biosafety Committee (IBC) services and streamlined processes to over 800 institutions comprising hundreds of actives sites around the world.


With WCG's Study Fast Start Solution, we can help you reduce your overall study start-up timelines by 35%, speed site enrollment by 30%, and cut site training costs by 50%.

WCG's flexible, on-demand solutions help sites reduce their study start-up timelines by 37%, boost financial results by 21%, and increase enrollment by 39%.

Interested in learning more about how you can meet your enrollment milestones by supporting the entire patient journey? Our WCG Site Augmentation experts are here to help your study team navigate the growing challenges of clinical research.

WCG's Safety Services helps clients drive efficiencies beyond traditional approaches to achieve high-quality trusted data, exceeding regulatory requirements, and increasing the likelihood of approval.

WCG’s technology-enabled safety solution measurably improves the safety distribution process through leveraging global expertise and proprietary technology, while addressing the three main sources of sponsor frustration.

Sponsors and CROs continue to face extreme challenges and high risks in the design and execution of clinical trials in support of new CNS therapies. WCG has built a global cohort of expert clinicians, proprietary cognitive assessments, targeted interventions, and supporting technology to reduce the risk of trial failure for the most complex and subjective indications.

Cell & Gene Therapy from WCG will help your teams navigate this ever-changing regulatory space and set your trials up for success.



212 Carnegie Center

Princeton, NJ 08540


Phone: 609-945-0120

Contact: Lauren Ozmore